PTEN interacts with p53 to promote tumor progression 40, and not only is TP53 mutation the most common genetic event in cancer, but it is also associated with more aggressive and inferior clinical outcomes in a variety of cancers, including EC 41. This evidence concerns the gene TP53 and neoplasm.